11.20.2018
Diagnostics
$973,997.00
85 months
Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
Funding to develop and validate outcome measurements to enable clinical development of anti-fibrotic therapies and allow for the non-invasive monitoring of stricturing disease progression in Crohn's disease patients.